Active	Status	Sponsor type	Region	Phase	Filter
6 Active 20 Inactive 26 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
D'Ettorre, Gabriella
EDOLAS, NCT04979468: Early DOlutegravir/LAmivudine Switching After Virological Suppression ( Study)	Recruiting	3	440	Europe	DOVATO, dolutegravir/lamivudine	Societa' Italiana Di Malattie Infettive E Tropicali	HIV-1-infection	04/23	04/24
RalAge2, NCT03579485: An Observational Retrospective Database Analysis to Evaluate Raltegravir Based-regimens, Including NUC-sparing Regimens, in Aged HIV Patients.(RalAge)	Recruiting	N/A	90	Europe		Azienda Policlinico Umberto I	Hiv	12/23	12/24
DORAge, NCT05202613: Non-Interventional Observational Retrospective Study to Evaluate Doravirine Based-regimens in HIV Infected Aged Patients ().	Recruiting	N/A	90	Europe	Doravirine	University of Roma La Sapienza	HIV	12/22	12/22
Ceccarelli, Giancarlo
RalAge2, NCT03579485: An Observational Retrospective Database Analysis to Evaluate Raltegravir Based-regimens, Including NUC-sparing Regimens, in Aged HIV Patients.(RalAge)	Recruiting	N/A	90	Europe		Azienda Policlinico Umberto I	Hiv	12/23	12/24
Pugliese, Francesco
SIRTI, NCT06649032: Survey of Incidence of Respiratory Tract Infections	Recruiting	N/A	2750	Europe	No intervention	Lallemand Pharma AG, Istituto di Farmacologia Traslazionale - National Research Council (IFT-CNR)	Healthy Adults, Not Healthy Adults	05/25	05/25
Mastroianni, Claudio M
G-COV, NCT04497402: Sex-Informed Data in the COVID-19 Pandemic.	Recruiting	N/A	88	Europe		University of Roma La Sapienza	Covid19	06/22	12/22
Calò, Andrea
No trials found
MAuro, Vera
No trials found
Zancla, Serena
No trials found
Recchia, Gregorio Egidio
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
D'Ettorre, Gabriella
EDOLAS, NCT04979468: Early DOlutegravir/LAmivudine Switching After Virological Suppression ( Study)	Recruiting	3	440	Europe	DOVATO, dolutegravir/lamivudine	Societa' Italiana Di Malattie Infettive E Tropicali	HIV-1-infection	04/23	04/24
RalAge2, NCT03579485: An Observational Retrospective Database Analysis to Evaluate Raltegravir Based-regimens, Including NUC-sparing Regimens, in Aged HIV Patients.(RalAge)	Recruiting	N/A	90	Europe		Azienda Policlinico Umberto I	Hiv	12/23	12/24
DORAge, NCT05202613: Non-Interventional Observational Retrospective Study to Evaluate Doravirine Based-regimens in HIV Infected Aged Patients ().	Recruiting	N/A	90	Europe	Doravirine	University of Roma La Sapienza	HIV	12/22	12/22
Ceccarelli, Giancarlo
RalAge2, NCT03579485: An Observational Retrospective Database Analysis to Evaluate Raltegravir Based-regimens, Including NUC-sparing Regimens, in Aged HIV Patients.(RalAge)	Recruiting	N/A	90	Europe		Azienda Policlinico Umberto I	Hiv	12/23	12/24
Pugliese, Francesco
SIRTI, NCT06649032: Survey of Incidence of Respiratory Tract Infections	Recruiting	N/A	2750	Europe	No intervention	Lallemand Pharma AG, Istituto di Farmacologia Traslazionale - National Research Council (IFT-CNR)	Healthy Adults, Not Healthy Adults	05/25	05/25
Mastroianni, Claudio M
G-COV, NCT04497402: Sex-Informed Data in the COVID-19 Pandemic.	Recruiting	N/A	88	Europe		University of Roma La Sapienza	Covid19	06/22	12/22
Calò, Andrea
No trials found
MAuro, Vera
No trials found
Zancla, Serena
No trials found
Recchia, Gregorio Egidio
No trials found